Essay

Disease Severity and Progression in Progressive Supranuclear Palsy and Multiple System Atrophy: Validation of the NNIPPS – PARKINSON PLUS SCALE

1.Litvan I, Mangone CA, McKee A, Verny M, Parsa A, et al. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry.1996; 60 :615–620. [PMC free article] [PubMed]

2.Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord.2003; 18 :467–486. [PubMed]

3.Testa D, Monza D, Ferrarini M, Soliveri P, Girotti F, et al. Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy. Neurol Sci.2001; 22 :247–251. [PubMed]

4.Ben-Shlomo Y, Wenning GK, Tison F, Quinn NP. Survival of patients with pathologically proven multiple system atrophy: a meta-analysis. Neurology.1997; 48 :384–93. [PubMed]

5.Golbe LI, Ohman-Strickland PA. A clinical rating scale for progressive supranuclear palsy. Brain.2007; 130 :1552–1565. [PubMed]

6.Schrag A, Ben-Shlomo Y, Quinn NP. Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet.1999; 354 :1771–1775. [PubMed]

7.Schrag A, Wenning GK, Quinn N, Ben-Shlomo Y. Survival in multiple system atrophy. Mov Disord.2008; 23 :294–296. [PubMed]

8.Bensimon G, Ludolph A, Agid Y, Vidailhet M, Payan C, et al. Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: The NNIPPS Study. Brain.2009; 132 :156–171. [PMC free article] [PubMed]

9.Robbins TW, James M, Owen AM, Lange KW, Lees AJ, et al. Cognitive deficits in progressive supranuclear palsy, Parkinson's disease and multiple system atrophy in tests sensitive to frontal lobe dysfunction. J Neurol Neurosurg Psychiatry.1994; 57 :79–88. [PMC free article] [PubMed]

10.Burk K, Daum I, Rub U. Cognitive function in multiple system atrophy of the cerebellar type. Mov Disord.2006; 21 :772–776. [PubMed]

11.Kroonenberg PM, Oort FJ, Stebbins GT, Leurgans SE, Cubo E, et al. Motor function in Parkinson's disease and supranuclear palsy: simultaneous factor analysis of a clinical scale in several populations. BMC Med Res Methodol.2006; 6 :26–39. [PMC free article] [PubMed]

12.Lyoo CH, Jeong Y, Ryu YH, Lee SY, Song TJ, et al. Effects of disease duration on the clinical features and brain glucose metabolism in patients with mixed type multiple system atrophy. Brain.2008; 131 :438–446. [PubMed]

13.Fahn S, Elton RL . UPDRS program members. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, editors.Recent developments in Parkinson's disease. Vol 2.Florham Park, NJ: MacMillan Health care Information; 1987. pp. 153–163.

14.Cubo E, Stebbins GT, Golbe LI, Nieves AV, Leurgans S, et al. Application of the Unified Parkinson's Disease Rating Scale in Progressive Supranuclear Palsy: Factor Analysis of the motor scale. Mov Disord.2000; 15 :276–279. [PubMed]

15.Seppi K, Yekhlef F, Diem A, Luginger Wolf E, Mueller J, et al. Progression of parkinsonism in multiple system atrophy. J Neurol.2005; 252 :91–96. [PubMed]

16.Tison F, Yekhlef F, Chrysostome V, Balestre E, Quinn NP, et al. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease. Mov Disord.2002; 17 :701–709. [PubMed]

17.Golbe LI, Lepore FE, Johnson WG, Belsh JM, Powell AL, et al. Inter-rater reliability of the Progressive Supranuclear Palsy Rating Scale. Neurology.1999; 52 (suppl 2):A227.

18.Wenning GK, Tison F, Seppi K, Sampaio C, Diem A, et al. Multiple System Atrophy Study Group. Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS). Mov Disord.2004; 19 :1391–1402. [PubMed]

19.Geser F, Wenning GK, Seppi K, Stampfer-Kountchev M, Scherfler C, et al. Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG). Mov Disord.2006; 21 :179–186. [PubMed]

20.Geser F, Seppi K, Stampfer-Kountchev M, Köllensperger M, Diem A, et al. The European Multiple System Atrophy-Study Group (EMSA-SG). J Neural Transm.2005; 112 :1677–1686. [PubMed]

21.Trouillas P, TakayanagI T, Hallett M, Currier RD, Subramony SH, et al. The Ataxia Neuropharmacology

The Best Essay Writing Service - EssayBox.org

Committee of the World Federation of Neurology. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. J Neurol Sci.1997; 145 :205–211. [PubMed]

22.Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology.1983; 33 :1444–1452. [PubMed]

23.Suarez GA, Opfer-Gehrking TL, Offord KP, Atkinson EJ, O'brien PC, et al. The Autonomic Symptom Profile: a new instrument to assess autonomic symptoms. Neurology.1999; 52 :523–528. [PubMed]

24.American Psychological Association, American Educational Research Association, National Council on Measurement in Education.Standards for educational and psychological testing.Washington DC: AERA Publication Sales press; 1999.

25.Nunnally JC, Bernstein IH.Psychometric theory (3rd ed.)New York: McGraw-Hill press; 1994.

26.Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology.1967; 17 :427–442. [PubMed]

27.Schwab R, England AJ. Projection techniques for evaluating surgery in Parkinson's Disease. In: Gillingham FJ, Donaldson IML, editors.Third symposium on Parkinson's Disease, Royal College of Surgeons.Edinburgh, Scotland: Livingstone; 1969. pp. 152–158.

28.Folstein MF, Folstein SE, McHugh PR. “Mini Mental State”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res.1975; 12 :189–198. [PubMed]

29.Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a frontal assessment battery at bedside. Neurology.2000; 55 :1621–1626. [PubMed]

30.Jenkinson C, Peto V, Fitzpatrick R, Greenhall R, Hyman N. The PDQ-8: development and validation of a short-form Parkinson's disease questionnaire. Psychol Health.1997; 12 :805–814.

31.Brazier JE, Harper R, Jones NMB, O'Cathain A, Westlake L, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ.1992; 305 :160–164. [PMC free article] [PubMed]

32.Cox DR. Regression models and life tables. J R Stat Soc.1972; 34 :187–220.

33.Fleiss JL. The measurement of inter-rater agreement. In: Bradley RA, Hunter JS, Kendal DG, Watson GS, editors.Statistical methods for rates and proportions (2nd ed.)New York: John Wiley & Sons Inc; 1981. pp. 212–236.

34.Cohen J. A coefficient of agreement for nominal scales. Educational and psychological measurements.1960; 20 :37–46.

35.Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull.1979; 86 :420–428. [PubMed]

36.Sim J, Wright CC. The Kappa Statistic in Reliability Studies: Use, Interpretation, and Sample Size Requirements. Phys Ther.2005; 85 :257–268. [PubMed]

37.Wu MC, Bailey K. Analysing change in the presence of informative right censoring caused by death and withdrawal, and staggered entry. Control Clin Trials.1988; 9 :32–46. [PubMed]

38.Cohen J.Statistical power analysis for the behavioral sciences (2nd ed.)Hillsdale, NJ: Lawrence Erlbaum Associates press; 1988.

39.May S, Gilman S, Sowell BB, Thomas RG, Stern MB, et al. Potential outcome measures and trial design issues for multiple system atrophy. Mov Disord.2007; 22 :2371–2377. [PubMed]

40.Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology.2008; 71 :670–676. [PMC free article] [PubMed]

41.Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol.1964; 10 :333–359. [PubMed]

42.Brown RG, Lacomblez L, Landwehrmeyer BG, Bak T, Uttner I, et al. Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. Brain.2010; 133 :2382–2393. [PubMed]

43.Aerts M, Bloem B. “This large observational study has generated unique and important new insights into the presence, severity…” Evaluation of: [Brown RG et al. Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. Brain. 2010 Aug; 133(Pt 8):2382–93; doi: 10.1093/brain/awq158]. 2011. Faculty of 1000, 21 Jan 2011. F1000.com/4671975.[PubMed]

44.Vanderhorst V, Tarsy D. “This study demonstrates that cognitive problems occur in the majority of patients with progressive supranuclear…” Evaluation of: [Brown RG et al. Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. Brain. 2010 Aug; 133(Pt 8):2382–93; doi: 10.1093/brain/awq158]. 2010. Faculty of 1000, 11 Aug 2010. F1000.com/4671975.[PubMed]


Category: Research paper

Similar articles: